The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medical membrane market size reached US$ 3.34 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.52 Billion by 2027, exhibiting a growth rate (CAGR) of 8.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Medical membrane refers to a technology utilized in drug delivery, tissue regeneration, artificial organs, and diagnostic devices. It assists in processing products with high purity and the concentration, separation and purification of various medical processes. It also aids in the treatment of patients suffering from various pathologies by removing toxins from the blood. It is used as a selective barrier to keep immune system components from encountering implants while allowing nutrients and metabolites to permeate the cells freely. As a result, it finds applications in hospitals, ambulatory centers, clinics, and community healthcare centers around the world.
There is currently a rise in the prevalence of chronic diseases like renal failure, diabetes, and atherosclerosis across the globe. This, along with the growing utilization of medical membrane in dialysis for filtration and blood purification, represents one of the key factors driving the market. Moreover, there is an increase in the employment of medical membranes in the recovery of concentrated proteins and enzymes. This, coupled with the rising awareness among individuals about the benefits of the medical membrane, is propelling the growth of the market. In addition, the escalating demand for medical membrane devices, such as microfiltration, intravenous (IV) infusion filters and sterile filtration, for curing various diseases is offering lucrative growth opportunities to industry investors. Besides this, the growing need for artificial organ implants due to organ failure is positively influencing the market. Apart from this, rising applications of ultra-pure water for manufacturing pharmaceutical products are catalyzing the demand for medical membranes. Additionally, the escalating demand for medical membrane in wastewater treatment as it has a higher selectivity towards critical components is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical membrane market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technology, material and application.
Breakup by Technology:
Breakup by Material:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), Hangzhou Cobetter Filtration Equipment Co. Ltd., Koch Separation Solutions (Koch Engineered Solutions), Medtronic plc, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific and W. L. Gore & Associates Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Technology, Material, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||3M Company, Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), Hangzhou Cobetter Filtration Equipment Co. Ltd., Koch Separation Solutions (Koch Engineered Solutions), Medtronic plc, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific and W. L. Gore & Associates Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at